These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15700047)

  • 21. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
    Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
    Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
    Knight S; Johns EJ
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
    Kim SH; Kim SH; Song YC; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction of endothelial dysfunction in patients with arterial hypertension.
    Soloviev MA; Kulakova NV; Semiglazova TA; Borodulina EV; Udut VV
    Bull Exp Biol Med; 2011 Jun; 151(2):183-5. PubMed ID: 22238745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model.
    Herbenick MA; Sprott D; Stills H; Lawless M
    Am J Orthop (Belle Mead NJ); 2008 Jul; 37(7):E133-7. PubMed ID: 18795192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    J Rheumatol Suppl; 1999 Apr; 56():31-6. PubMed ID: 10225538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of celecoxib and nimesulide on the proliferation of ectopic endometrial stromal cells in vitro.
    Kong B; Tian Y; Zhu W; Su S; Kan Y
    J Int Med Res; 2008; 36(5):1032-8. PubMed ID: 18831898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A combination of docosahexaenoic acid and celecoxib prevents prostate cancer cell growth in vitro and is associated with modulation of nuclear factor-kappaB, and steroid hormone receptors.
    Narayanan NK; Narayanan BA; Reddy BS
    Int J Oncol; 2005 Mar; 26(3):785-92. PubMed ID: 15703837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.
    Jung KH; Chu K; Lee ST; Kim J; Sinn DI; Kim JM; Park DK; Lee JJ; Kim SU; Kim M; Lee SK; Roh JK
    Neurobiol Dis; 2006 Aug; 23(2):237-46. PubMed ID: 16806953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib, a COX-2--specific inhibitor: the clinical data.
    Fort J
    Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):13-8. PubMed ID: 10193998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-training intrahippocampal infusion of the COX-2 inhibitor celecoxib impaired spatial memory retention in rats.
    Sharifzadeh M; Naghdi N; Khosrovani S; Ostad SN; Sharifzadeh K; Roghani A
    Eur J Pharmacol; 2005 Mar; 511(2-3):159-66. PubMed ID: 15792784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The new NSAIDs: cox-2 inhibitors.
    Capriotti T
    Medsurg Nurs; 2000 Dec; 9(6):313-7. PubMed ID: 11904867
    [No Abstract]   [Full Text] [Related]  

  • 36. Celecoxib enhances the detoxification of diethylnitrosamine in rat liver cancer.
    Salcido-Neyoy ME; Sierra-Santoyo A; Beltrán-Ramírez O; Macías-Pérez JR; Villa-Treviño S
    World J Gastroenterol; 2009 May; 15(19):2345-50. PubMed ID: 19452576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
    FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
    Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
    Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
    Vegeler RC; Yip-Schneider MT; Ralstin M; Wu H; Crooks PA; Neelakantan S; Nakshatri H; Sweeney CJ; Schmidt CM
    J Surg Res; 2007 Nov; 143(1):169-76. PubMed ID: 17950089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.